Cite
HARVARD Citation
Kurimoto, E. et al. (2021). Therapeutic potential of TAK-071, a muscarinic M1 receptor positive allosteric modulator with low cooperativity, for the treatment of cognitive deficits and negative symptoms associated with schizophrenia. Neuroscience letters. p. . [Online].